Still time to register for SLAS Transformed 2020

22 June 2020

SLAS Transformed is an interactive event focused on omics, synthetic biology and genome editing along with applicable implications for the current pandemic.

The two-day event runs from 23-24 June 2020, offering 30-minute scientific research presentations, live exhibitor presentations and one-on-one networking sessions.

It will span multiple time zones (6.30am-8pm) US Central and will showcase:

  • expert speakers from academia, pharma, platform technology companies
  • real-time Q&As with the presenters
  • Live tutorials with one- on-one discussion and access (until 30 June) to the attendee partnering tool to help you connect with potential collaborators.

SLAS Transformed is aimed at academic researchers, entrepreneurs, ‘next-gen’ screeners, data scientists, computational biologists and those working on the clinical or validation side of lab research.

Synthetic biology

The world has embarked on something new: the ability to revolutionise the practice of science and production through manipulation of organisms at the genetic level. Speakers at SLAS Transformed utilise tools like CRISPR, RNA-Seq, and gene silencing to treat immune diseases, develop new diagnostic paradigms and change how drugs are produced.

Attendees will gain new knowledge around how to deliver gene therapies using edited antibodies, produce living circuits and respond to the COVID-19 pandemic through gene detection.

Omics – Measurement Matters

At the heart of this new wave of computationally-enhanced biology is the ability to track, interpret and predict changes in multiple health-related systems. At SLAS Transformed, speakers will discuss ‘omics of the vanishingly small – at the single-cell level – or expansive, such as population genomics tracking diseases over time.

Attendees will learn about instrumentation to assist their ‘omics campaigns as well as ultrasensitive diagnostics based on protein and genetic biomarkers.

Pandemic preparation

The SLAS community has marshalled expertise in screening, diagnostic development, vaccine testing and data analysis to face the COVID-19 challenge. Speakers at SLAS Transformed will discuss digital, diagnostic and SynBio approaches to pandemic resolution, including development of CRISPR-based detection strategies, contact tracing networks, AI-informed drug design and open-source repurposing campaigns.

Attendees will learn new approaches to tackling the coronavirus and preparing the populace for future viral challenges.

Image: Thomas Lefebvre




Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free